Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients

Gemma Caterina Maria Rossi, Gian Maria Pasinetti, Luigia Scudeller, Marta Raimondi, Sara Lanteri, Paolo Emilio Bianchi

Research output: Contribution to journalArticle

Abstract

Purpose. To identify risk factors for developing ocular surface disease (OSD), to verify the prevalence of OSD, and to record efficacy of questionnaires in identifying symptoms' impact on patients' quality of life. Methods. This was an observational, cross-sectional study of patients with topically treated glaucoma. Tear film break-up time (TFBUT) and punctate keratitis were evaluated; 2 quality-of-life questionnaires (National Eye Institute-Visual Function Questionnaire 25 and Glaucoma Symptom Scale) were submitted to all patients. Class of previous and current intraocular pressure (IOP)-lowering drugs, number of drugs, number of drops/day, and total and current benzalkonium chloride (BAK) exposure were collected. results. A total of 233 patients completed the study. TFBUT was abnormal in 71 (30.5%) eyes; punctate keratitis was present in 74 (31.7%). Keratitis was more frequent with increasing number of eye-drops (p=0.008) and number of instillations per day (p=0.009). Ocular surface disease was present in 97 (41.6%) patients and was statistically related to number of medications used (p=0.026). The univariate analysis pointed out that patients with OSD were older (p=0.04), had lower IOP values (p=0.03), were topically treated for more time (p

Original languageEnglish
Pages (from-to)296-302
Number of pages7
JournalEuropean Journal of Ophthalmology
Volume23
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Ocular Hypertension
Eye Diseases
Glaucoma
Keratitis
Tears
Intraocular Pressure
National Eye Institute (U.S.)
Quality of Life
Benzalkonium Compounds
Ophthalmic Solutions
Pharmaceutical Preparations
Cross-Sectional Studies
Surveys and Questionnaires

Keywords

  • BAK
  • Glaucoma
  • Ocular surface disease
  • Risk factor
  • Therapy

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients. / Rossi, Gemma Caterina Maria; Pasinetti, Gian Maria; Scudeller, Luigia; Raimondi, Marta; Lanteri, Sara; Bianchi, Paolo Emilio.

In: European Journal of Ophthalmology, Vol. 23, No. 3, 2013, p. 296-302.

Research output: Contribution to journalArticle

@article{28763b32a1314d2abbe7e64939eff289,
title = "Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients",
abstract = "Purpose. To identify risk factors for developing ocular surface disease (OSD), to verify the prevalence of OSD, and to record efficacy of questionnaires in identifying symptoms' impact on patients' quality of life. Methods. This was an observational, cross-sectional study of patients with topically treated glaucoma. Tear film break-up time (TFBUT) and punctate keratitis were evaluated; 2 quality-of-life questionnaires (National Eye Institute-Visual Function Questionnaire 25 and Glaucoma Symptom Scale) were submitted to all patients. Class of previous and current intraocular pressure (IOP)-lowering drugs, number of drugs, number of drops/day, and total and current benzalkonium chloride (BAK) exposure were collected. results. A total of 233 patients completed the study. TFBUT was abnormal in 71 (30.5{\%}) eyes; punctate keratitis was present in 74 (31.7{\%}). Keratitis was more frequent with increasing number of eye-drops (p=0.008) and number of instillations per day (p=0.009). Ocular surface disease was present in 97 (41.6{\%}) patients and was statistically related to number of medications used (p=0.026). The univariate analysis pointed out that patients with OSD were older (p=0.04), had lower IOP values (p=0.03), were topically treated for more time (p",
keywords = "BAK, Glaucoma, Ocular surface disease, Risk factor, Therapy",
author = "Rossi, {Gemma Caterina Maria} and Pasinetti, {Gian Maria} and Luigia Scudeller and Marta Raimondi and Sara Lanteri and Bianchi, {Paolo Emilio}",
year = "2013",
doi = "10.5301/ejo.5000220",
language = "English",
volume = "23",
pages = "296--302",
journal = "European Journal of Ophthalmology",
issn = "1120-6721",
publisher = "Wichtig Publishing",
number = "3",

}

TY - JOUR

T1 - Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients

AU - Rossi, Gemma Caterina Maria

AU - Pasinetti, Gian Maria

AU - Scudeller, Luigia

AU - Raimondi, Marta

AU - Lanteri, Sara

AU - Bianchi, Paolo Emilio

PY - 2013

Y1 - 2013

N2 - Purpose. To identify risk factors for developing ocular surface disease (OSD), to verify the prevalence of OSD, and to record efficacy of questionnaires in identifying symptoms' impact on patients' quality of life. Methods. This was an observational, cross-sectional study of patients with topically treated glaucoma. Tear film break-up time (TFBUT) and punctate keratitis were evaluated; 2 quality-of-life questionnaires (National Eye Institute-Visual Function Questionnaire 25 and Glaucoma Symptom Scale) were submitted to all patients. Class of previous and current intraocular pressure (IOP)-lowering drugs, number of drugs, number of drops/day, and total and current benzalkonium chloride (BAK) exposure were collected. results. A total of 233 patients completed the study. TFBUT was abnormal in 71 (30.5%) eyes; punctate keratitis was present in 74 (31.7%). Keratitis was more frequent with increasing number of eye-drops (p=0.008) and number of instillations per day (p=0.009). Ocular surface disease was present in 97 (41.6%) patients and was statistically related to number of medications used (p=0.026). The univariate analysis pointed out that patients with OSD were older (p=0.04), had lower IOP values (p=0.03), were topically treated for more time (p

AB - Purpose. To identify risk factors for developing ocular surface disease (OSD), to verify the prevalence of OSD, and to record efficacy of questionnaires in identifying symptoms' impact on patients' quality of life. Methods. This was an observational, cross-sectional study of patients with topically treated glaucoma. Tear film break-up time (TFBUT) and punctate keratitis were evaluated; 2 quality-of-life questionnaires (National Eye Institute-Visual Function Questionnaire 25 and Glaucoma Symptom Scale) were submitted to all patients. Class of previous and current intraocular pressure (IOP)-lowering drugs, number of drugs, number of drops/day, and total and current benzalkonium chloride (BAK) exposure were collected. results. A total of 233 patients completed the study. TFBUT was abnormal in 71 (30.5%) eyes; punctate keratitis was present in 74 (31.7%). Keratitis was more frequent with increasing number of eye-drops (p=0.008) and number of instillations per day (p=0.009). Ocular surface disease was present in 97 (41.6%) patients and was statistically related to number of medications used (p=0.026). The univariate analysis pointed out that patients with OSD were older (p=0.04), had lower IOP values (p=0.03), were topically treated for more time (p

KW - BAK

KW - Glaucoma

KW - Ocular surface disease

KW - Risk factor

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84876584468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876584468&partnerID=8YFLogxK

U2 - 10.5301/ejo.5000220

DO - 10.5301/ejo.5000220

M3 - Article

C2 - 23335308

AN - SCOPUS:84876584468

VL - 23

SP - 296

EP - 302

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

SN - 1120-6721

IS - 3

ER -